T0	Participants 64 85	children with autism.
T1	Participants 520 541	children with autism.
T2	Participants 624 663	NAC in children with autistic disorder.
T3	Participants 1106 1216	Thirty-three subjects (31 male subjects, 2 female subjects; aged 3.2-10.7 years) were randomized in the study.
T4	Participants 1249 1306	14 subjects in the NAC group and 15 in the placebo group.
T5	Participants 1602 1634	children with autistic disorder.